Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mutant α2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome
Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle
Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle
View: Text | PDF
Research Article Neuroscience Ophthalmology

Mutant α2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome

  • Text
  • PDF
Abstract

Duane retraction syndrome (DRS) is the most common form of congenital paralytic strabismus in humans and can result from α2-chimaerin (CHN1) missense mutations. We report a knockin α2-chimaerin mouse (Chn1KI/KI) that models DRS. Whole embryo imaging of Chn1KI/KI mice revealed stalled abducens nerve growth and selective trochlear and first cervical spinal nerve guidance abnormalities. Stalled abducens nerve bundles did not reach the orbit, resulting in secondary aberrant misinnervation of the lateral rectus muscle by the oculomotor nerve. By contrast, Chn1KO/KO mice did not have DRS, and embryos displayed abducens nerve wandering distinct from the Chn1KI/KI phenotype. Murine embryos lacking EPH receptor A4 (Epha4KO/KO), which is upstream of α2-chimaerin in corticospinal neurons, exhibited similar abducens wandering that paralleled previously reported gait alterations in Chn1KO/KO and Epha4KO/KO adult mice. Findings from Chn1KI/KI Epha4KO/KO mice demonstrated that mutant α2-chimaerin and EphA4 have different genetic interactions in distinct motor neuron pools: abducens neurons use bidirectional ephrin signaling via mutant α2-chimaerin to direct growth, while cervical spinal neurons use only ephrin forward signaling, and trochlear neurons do not use ephrin signaling. These findings reveal a role for ephrin bidirectional signaling upstream of mutant α2-chimaerin in DRS, which may contribute to the selective vulnerability of abducens motor neurons in this disorder.

Authors

Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle

×

Figure 3

EphA4 is required for normal abducens nerve development.

Options: View larger image (or click on image) Download as PowerPoint
EphA4 is required for normal abducens nerve development.
(A) Model of ba...
(A) Model of balanced WT attractant and repellent guidance cues surrounding developing abducens nerve. Left: hindbrain and black abducens nucleus, right: black orbit and red EOM; left and right connected by abducens nerve in black. Green triangles, attractant cues; orange triangles, repellent cues. (B and C) Percentage of WT axons in abducens explants exhibiting growth cone collapse (B) and axon shaft retraction (C) after addition of FC, ephrin-A5, ephrin-B1, or ephrin-B2 (n ≥ 95 axons from ≥3 experiments for each cue). *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey’s test; data represent mean ± SEM. (D and E) Images of abducens growth cones before (D) and after (E) addition of 200 ng/ml ephrin-A5. (F) Ephrin-A5–AP binding to bilateral E11.5 WT abducens nuclei (nVI) in an open-book hindbrain preparation. Top: Hb9-GFP–positive abducens nuclei before assay; bottom: ephrin-A5–AP binding to same tissue; n = 2. (G) Epha4 (red) and Hb9-GFP (green) fluorescence ISH on sagittal section of E11.5 WT abducens nucleus. Scale bar: 50 μm. (H and I) Whole mount neurofilament staining in E11.5 Epha4WT/WT (H) and Epha4KO/KO (I) embryos. n = 5 embryos; arrow, misprojection with facial nerve; arrowhead, dorsal projections to hindbrain; red, neurofilament; green, Hb9-GFP. Scale bar: 100 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts